Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.44% | 155.42% | -102.32% | -130.45% | -730.30% |
| Total Depreciation and Amortization | 9.51% | 147.69% | -366.01% | 3.05% | -15.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.21% | -49.42% | -8.85% | 3.12% | -5.21% |
| Change in Net Operating Assets | -117.20% | 258.89% | -521.33% | 206.80% | 77.31% |
| Cash from Operations | -76.66% | 258.32% | -663.10% | 123.80% | 133.19% |
| Capital Expenditure | 20.14% | -43.05% | 13.73% | -21.62% | -207.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.42% | 87.75% | -626.77% | -113.10% | 296.43% |
| Cash from Investing | 99.37% | 85.52% | -545.07% | -115.25% | 298.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,243.33% | -94.92% | 93.77% | -56.61% | 226.98% |
| Repurchase of Common Stock | 77.36% | 14.19% | -64.96% | 34.15% | 73.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 105.29% | 8.64% | -63.29% | 32.12% | 75.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.07% | 184.98% | -8,042.71% | -95.76% | 184.92% |